ARS Pharmaceuticals, Inc. (SPRY)

SEC filing

ARS Pharmaceuticals, Inc.

SPRY · CIK 1671858

4 · Oct 5, 2026 · Director, President and CEO Casale Donn was granted 1.04M Stock Option (right to buy)

Director, President and CEO Casale Donn was granted 1.04M Stock Option (right to buy)

xslF345X06/form4-10052026_081042.xml

xslF345X06/form4-10052026_081042.xmlSEC.gov

Graphics and non-inline formats (not embedded below).